Coronavirus: Israel

Department for Business, Energy and Industrial Strategy written question – answered on 2nd June 2020.

Alert me about debates like this

Photo of Lord Turnberg Lord Turnberg Labour

To ask Her Majesty's Government what assessment they have made of the research into COVID-19 by the MIGAL Research Institute in Israel and the potential effectiveness of their orally-administered vaccine Migvax.

Photo of Lord Callanan Lord Callanan Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy)

The Vaccines Taskforce is working with experts, as appointed by Kate Bingham as Chair, to assess the range of SARS-CoV-2 vaccine candidates being developed around the world. As part of this assessment, Government will evaluate the MIGAL Research Institute’s orally-administered, viral vector-based vaccine.

Companies and research institutes are welcome to submit proposals to UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR) research calls. Government support is available to prioritise, coordinate and deliver studies which qualify as urgent public health research.

Does this answer the above question?

Yes2 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.